Morgan Stanley sells INCY common shares (INCY) via Form 144 notice
Rhea-AI Filing Summary
Morgan Stanley Smith Barney LLC Executive Financial Services reported a proposed sale of Common shares of INCY via a Form 144 filed 05/26/2026. The filing lists multiple lots tied to Restricted Stock dated 07/02/2023 and Employee Stock Purchase Plan dated 04/30/2025, with specific share line items shown.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 notice of proposed resale by a broker/dealer.
The filing lists proposed sales of Common stock associated with restricted stock and an employee stock purchase plan, and shows dates and line-item counts. This form records an intended resale under Rule 144, not a completed public sale.
Cash‑flow treatment and settlement timing are not disclosed in the excerpt; subsequent transaction reports would show execution. Regulatory compliance depends on Rule 144 conditions and any contractual transfer restrictions linked to the noted grant dates.
Administrative resale filing with limited market impact.
The entries include line items of Common shares tied to broker information and grant/purchase plan dates. The listing of lots dated 07/02/2023 and 04/30/2025 indicates the source of shares but not execution quantities beyond the table lines.
Whether these shares create immediate supply depends on whether the proposed sales are executed; timing and sizes executed are not provided in this excerpt.